Effectiveness of dapagliflozin on vascular endothelial function and glycemic control in patients with early-stage type 2 diabetes mellitus: DEFENCE study

BACKGROUND: Recent studies reported that sodium glucose cotransporter 2 (SGLT2) inhibitors can potentially reduce the risk of cardiovascular mortality in patients with type 2 diabetes mellitus (T2DM). However, there is little or no information on the therapeutic effects of SGLT2 inhibitors on the pr...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Cardiovasc Diabetol
Autores principales: Shigiyama, Fumika, Kumashiro, Naoki, Miyagi, Masahiko, Ikehara, Kayoko, Kanda, Eiichiro, Uchino, Hiroshi, Hirose, Takahisa
Formato: Artigo
Lenguaje:Inglês
Publicado: BioMed Central 2017
Materias:
Original Investigation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5500953/
https://ncbi.nlm.nih.gov/pubmed/28683796
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12933-017-0564-0
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares